These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

347 related articles for article (PubMed ID: 21770765)

  • 21. Relationship of cytokines, oxidative stress and GI motility with bacterial overgrowth in ulcerative colitis patients.
    Rana SV; Sharma S; Kaur J; Prasad KK; Sinha SK; Kochhar R; Malik A; Morya RK
    J Crohns Colitis; 2014 Aug; 8(8):859-65. PubMed ID: 24456736
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Lubiprostone Accelerates Intestinal Transit and Alleviates Small Intestinal Bacterial Overgrowth in Patients With Chronic Constipation.
    Sarosiek I; Bashashati M; Alvarez A; Hall M; Shankar N; Gomez Y; McCallum RW; Sarosiek J
    Am J Med Sci; 2016 Sep; 352(3):231-8. PubMed ID: 27650225
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Small intestinal bacterial overgrowth in gastroparesis: are there any predictors?
    Reddymasu SC; McCallum RW
    J Clin Gastroenterol; 2010 Jan; 44(1):e8-13. PubMed ID: 20027008
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Influence of alcohol on gastrointestinal motility: lactulose breath hydrogen testing in orocecal transit time in chronic alcoholics, social drinkers and teetotaler subjects.
    Addolorato G; Montalto M; Capristo E; Certo M; Fedeli G; Gentiloni N; Stefanini GF; Gasbarrini G
    Hepatogastroenterology; 1997; 44(16):1076-81. PubMed ID: 9261602
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Small intestinal bacterial overgrowth and orocecal transit time in patients of nonalcoholic fatty liver disease.
    Shi H; Mao L; Wang L; Quan X; Xu X; Cheng Y; Zhu S; Dai F
    Eur J Gastroenterol Hepatol; 2021 Dec; 33(1S Suppl 1):e535-e539. PubMed ID: 33867442
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Transient lactose malabsorption in patients affected by symptomatic uncomplicated diverticular disease of the colon.
    Tursi A; Brandimarte G; Giorgetti GM; Elisei W
    Dig Dis Sci; 2006 Mar; 51(3):461-5. PubMed ID: 16614952
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Gastrointestinal motility disorder assessment in systemic sclerosis.
    Savarino E; Mei F; Parodi A; Ghio M; Furnari M; Gentile A; Berdini M; Di Sario A; Bendia E; Bonazzi P; Scarpellini E; Laterza L; Savarino V; Gasbarrini A
    Rheumatology (Oxford); 2013 Jun; 52(6):1095-100. PubMed ID: 23382360
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Combined oro-caecal scintigraphy and lactulose hydrogen breath testing demonstrate that breath testing detects oro-caecal transit, not small intestinal bacterial overgrowth in patients with IBS.
    Yu D; Cheeseman F; Vanner S
    Gut; 2011 Mar; 60(3):334-40. PubMed ID: 21112950
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Cisapride decreasing orocecal transit time in patients with nonalcoholic steatohepatitis.
    Fu XS; Jiang F
    Hepatobiliary Pancreat Dis Int; 2006 Nov; 5(4):534-7. PubMed ID: 17085338
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Erosive esophagitis may be related to small intestinal bacterial overgrowth.
    Kim KM; Kim BT; Lee DJ; Park SB; Joo NS; Kim YS; Kim KN
    Scand J Gastroenterol; 2012 May; 47(5):493-8. PubMed ID: 22416969
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Malabsorption, Orocecal Transit Time and Small Intestinal Bacterial Overgrowth in Type 2 Diabetic Patients: A Connection.
    Rana SV; Malik A; Bhadada SK; Sachdeva N; Morya RK; Sharma G
    Indian J Clin Biochem; 2017 Mar; 32(1):84-89. PubMed ID: 28149017
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Lactose malabsorption in the elderly: role of small intestinal bacterial overgrowth.
    Almeida JA; Kim R; Stoita A; McIver CJ; Kurtovic J; Riordan SM
    Scand J Gastroenterol; 2008; 43(2):146-54. PubMed ID: 18224561
    [TBL] [Abstract][Full Text] [Related]  

  • 33. The prevalence of small intestinal bacterial vergrowth in irritable bowel syndrome.
    Mann NS; Limoges-Gonzales M
    Hepatogastroenterology; 2009; 56(91-92):718-21. PubMed ID: 19621689
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Small intestine bacterial overgrowth in patients with chronic diarrhea and normal control subjects].
    Torres Lam R; León Barúa R; Berendson Seminario R; Curioso Vílchez W; Roe Battistini E; Biber Poillevard M
    Rev Gastroenterol Peru; 2003; 23(2):111-4. PubMed ID: 12853987
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Small bowel bacterial overgrowth and type 1 diabetes.
    Ojetti V; Pitocco D; Scarpellini E; Zaccardi F; Scaldaferri F; Gigante G; Gasbarrini G; Ghirlanda G; Gasbarrini A
    Eur Rev Med Pharmacol Sci; 2009; 13(6):419-23. PubMed ID: 20085122
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Small intestinal bacterial overgrowth in North Indian patients with celiac disease.
    Rana SV; Sinha SK; Lal S; Sikander A; Singh K
    Trop Gastroenterol; 2007; 28(4):159-61. PubMed ID: 18416345
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Small intestine bacterial overgrowth is frequent in cystic fibrosis: combined hydrogen and methane measurements are required for its detection.
    Lisowska A; Wójtowicz J; Walkowiak J
    Acta Biochim Pol; 2009; 56(4):631-4. PubMed ID: 19997657
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Utility of hydrogen breath tests in diagnosis of small intestinal bacterial overgrowth in malabsorption syndrome and its relationship with oro-cecal transit time.
    Ghoshal UC; Ghoshal U; Das K; Misra A
    Indian J Gastroenterol; 2006; 25(1):6-10. PubMed ID: 16567886
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Type 1 diabetes mellitus: Complex interplay of oxidative stress, cytokines, gastrointestinal motility and small intestinal bacterial overgrowth.
    Malik A; Morya RK; Bhadada SK; Rana S
    Eur J Clin Invest; 2018 Nov; 48(11):e13021. PubMed ID: 30155878
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Small intestinal bacterial overgrowth and delayed orocecal transit time in patients with cirrhosis and low-grade hepatic encephalopathy.
    Lunia MK; Sharma BC; Sachdeva S
    Hepatol Int; 2013 Mar; 7(1):268-73. PubMed ID: 26201641
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 18.